Compartir
Este es el nuevo punto de información pensado para personal médico y pacientes sobre coronavirus de Elsevier. Aquí encontrará información experta y de calidad para la comunidad científica y los profesionales de la salud sobre el nuevo coronavirus (también denominado COVID-19 y 2019-nCoV)
Todos los recursos son de libre acceso para personal sanitario y pacientes.
Seleccione una especialidad
Response to the letter to the editor: A comment on C-reactive protein and SOFA scale: a simple scale as an early predictor of the need for critical care in patients with COVID-19 pneumonia in Spain
Luis Mario Vaquero Roncero, Elisa Sánchez Barrado, Miguel Vicente Sánchez Hernández
10.1016/j.redare.2022.07.003
Revista Española de Anestesiología y Reanimación (English Version). 2022;69:442-3
Acceso a texto completo
A commentary on “C-Reactive protein and SOFA scale: A simple score as early predictor of critical care requirement in patients with COVID-19 pneumonia in Spain” (Revista Española de Anestesiología y Reanimación 68 (2021) 513−522)
D.A. Vergara Maestre, M.A. Toro Muñoz
10.1016/j.redare.2021.11.003
Revista Española de Anestesiología y Reanimación (English Version). 2022;69:443-4
Acceso a texto completo
Cardiovascular risk in type 1 and type 2 diabetes: Differences, similarities and insights
Emilio Ortega Martinez De Victoria, Clara Viñals Doménech
10.1016/j.endien.2022.08.004
Endocrinol Diabetes Nutr. 2022;69:455-7
Acceso a texto completo
Role of therapeutic inertia in glycemic control according to individualized objectives in a cohort of patients with type 2 diabetes. Results from CONCARDIA2
Abraham Hidalgo Rodríguez, David Martín Enguix, Juan Carlos Aguirre Rodríguez, María Sánchez Cambronero
10.1016/j.endien.2022.07.003
Endocrinol Diabetes Nutr. 2022;69:458-65
Acceso a texto completo
Glycaemic control during the COVID-19 pandemic: A catastrophe or a sign of hope for the person with type 1 Diabetes Mellitus?
Diogo Ramalho, Ana Rouxinol-Dias, Patrícia Tavares, Sara Correia, Lúcia Almeida, Helena Alves, Gustavo Rocha, Maria João Oliveira
10.1016/j.endien.2022.08.003
Endocrinol Diabetes Nutr. 2022;69:476-82
Acceso a texto completo
Epidemiology and resource use in Spanish type 2 diabetes patients without previous cardiorenal disease: CaReMe Spain study summary
Antoni Sicras-Mainar, Aram Sicras-Navarro, Beatriz Palacios, Miren Sequera, Julia Blanco, Antonio Hormigo, Nicolas Manito, Roberto Alcázar-Arroyo, Manuel Antonio Botana-Lopez
10.1016/j.endien.2022.07.005
Endocrinol Diabetes Nutr. 2022;69:509-19
Acceso a texto completo
Likely impact of COVID-19 on referrals to pediatric endocrinology: Increased incidence of precocious puberty in a third-level hospital
Ana Belén Ariza Jimenez, Francisco Javier Aguilar Gomez-Cardenas, Carmen de la Camara Moraño
10.1016/j.endien.2022.07.002
Endocrinol Diabetes Nutr. 2022;69:542-4
Acceso a texto completo
Acute hyperglycemic crises with sodium-glucose co-transporter-2 inhibitors across the cardiovascular and renal outcome trials: An anticipated fear?
Dimitrios Patoulias, Christodoulos Papadopoulos, Michael Doumas
10.1016/j.endien.2022.06.011
Endocrinol Diabetes Nutr. 2022;69:547-9
Acceso a texto completo
A significant dilemma in the treatment of heart failure patients with sacubitril/valsartan or sodium-glucose co-transporter 2 inhibitors: Whether to add mineralocorticoid receptor antagonists
Dimitrios Patoulias, Christodoulos Papadopoulos, Konstantinos Stavropoulos, Konstantinos Imprialos, Aristi Boulmpou, Michael Doumas
10.1016/j.repc.2021.10.009
Rev Port Cardiol. 2022;41:705-7
Open access
Myocarditis and COVID-19 mRNA vaccination
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
10.1016/j.repc.2021.08.009
Rev Port Cardiol. 2022;41:727
Open access